JP

Hiroaki Asai

This inventor holds 0 USPTO granted patents, plus 8 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroaki Asai. Retrieved from https://idiyas.com/inventor/hiroaki-asai-c0jbgva9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Hiroaki Asai: Innovator in Allergy Treatment

Introduction

Hiroaki Asai is a notable inventor based in Japan, recognized for his contributions to the field of allergy treatment. His innovative work focuses on developing agents that can prevent and treat various allergic diseases.

Latest Patents

Hiroaki Asai holds a patent for a Low-Molecular Polysulfated Hyaluronic Acid Derivative and compositions containing the same. This invention serves as an agent for the prevention and/or treatment of allergic diseases, including pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma. The patent is represented by the general formula (IA) or (IB), where 'n' can range from 0 to 15, and 'R's can independently represent a hydrogen atom or an SO3H group, among others.

Career Highlights

Throughout his career, Hiroaki Asai has focused on innovative solutions to combat allergic conditions. His research has contributed significantly to the understanding and treatment of these diseases, showcasing his commitment to improving patient outcomes.

Collaborations

Hiroaki Asai has collaborated with Satoshi Shimizu, working together to advance their research in allergy treatment. Their partnership has led to significant developments in the field.

Conclusion

Hiroaki Asai's work in developing treatments for allergic diseases highlights his role as an important inventor in the medical field. His innovative approaches continue to pave the way for advancements in allergy management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…